Search Medical Condition
Please enter condition
Please choose location
 

Arnsberg, Germany Clinical Trials

A listing of Arnsberg, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (16) clinical trials

VIRTUS: An Evaluation of the Veniti Vici Venous Stent System in Patients With Chronic Iliofemoral Venous Outflow Obstruction

The objective of this prospective study is to assess the safety and efficacy of the Veniti Vici Venous Stent System in achieving patency of the target venous lesion in patients with clinically significant chronic non-malignant obstruction of the iliofemoral venous outflow tract.

Phase N/A

0.0 miles

Learn More »

Stellarex Vascular E-Registry

Prospective, international, multi-center, single arm, observational study to continue to assess the treatment by the Stellarex OTW Drug-coated Angioplasty Balloon in superficial femoral and/or popliteal arteries according to the Instructions for Use in a broad, real-world, claudicant or ischemic rest pain patients population per the institution's standard practice.

Phase N/A

0.0 miles

Learn More »

Tack Optimized Drug Coated Balloon Angioplasty Study of the Tack Endovascular System in Femoropoliteal Arteries

This is an Outside the United States, post-CE Mark, multi-center, single-arm, non-blinded study designed to investigate the safety and efficacy of the Tack Endovascular System. This study will evaluate subjects with PAD who receive PTA (with a drug-coated balloon (DCB)) in the SFA and in popliteal arteries, ranging in diameter ...

Phase N/A

0.0 miles

Learn More »

Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries

The study will enroll patients presenting with claudication, or critical limb ischemia (Rutherford Category 3- 5) and an angiographically significant (≥ 70%) native artery lesion appropriate for angioplasty that is below the knee. Subjects will be treated with the Lutonix Drug Coated Balloon (DCB) carrying the CE Mark per current ...

Phase N/A

0.0 miles

Learn More »

Local Paclitaxel or Balloon Angioplasty Below the Knee

After successful guide wire passage of the below the knee index lesions the patients will either receive a treatment with a conventional uncoated balloon or a balloon coated with paclitaxel. Only patients who require follow-up angiography after 6 months will be included in this study. The primary endpoint (index vessel ...

Phase N/A

0.0 miles

Learn More »

Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions

Patients with chronic stenotic or occlusive atherosclerotic disease and lesions of at least 13 cm length in the SFA or Arteria poplitea segment 1 will be randomized to either treatment with paclitaxel coated balloon catheter, paclitaxel coated stent or bare nitinol stent. Vessel patency will be evaluated by quantitative angiography ...

Phase N/A

0.0 miles

Learn More »

Documentation of Humira in Psoriasis Patients in Routine Clinical Practice

Postmarketing Observational Study to Evaluate the Work Productivity, Safety and Efficacy of Humira for the Treatment of Moderate to Severe Plaque Psoriasis in Daily Clinical Practice. The primary objectives of the PMOS are to explore changes in health related care utilization data by the evaluation of: the number of missed ...

Phase N/A

2.35 miles

Learn More »

Treatment of Femoro-popliteal Atherosclerotic Lesions Using the Ranger Paclitaxel Coated Balloon Catheter. All Comers Registry.

A total of up to 250 patients from an all-comers patient population with infrainguinal atherosclerotic disease who are implanted or scheduled for an implant with a Ranger Drug coated balloon. Interim analysis will be carried out for every 50 subjects enrolled.

Phase N/A

2.75 miles

Learn More »

The DESappear Study: Drug Eluting Scaffold

This is a mutli center, prospective ,single arm study enrolling up to 60 patients at up to 12 centers in New Zealand and Europe. The purpose is to prospectively collect information to evaluate the safety and performance of the Akesys Prava Sirolimus eluting bioresorbable scaffold system in peripheral arterial disease ...

Phase N/A

2.75 miles

Learn More »

Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)

Shockwave Medical Inc. intends to conduct a prospective, multi-center, single blind, randomized (1:1) study of Lithoplasty treatment used in combination with DCB versus standard balloon angioplasty used in combination with DCB to treat moderate and severely calcified femoropopliteal arteries. The Shockwave Medical Peripheral Lithoplasty System is indicated for lithotripsy-enhanced, low-pressure ...

Phase N/A

2.75 miles

Learn More »